Volume 15, Number 3, September 2008Xth European Multicolloquium of Parasitology (EMOP-10, Paris, August 24-28, 2008)
|Page(s)||510 - 514|
|Published online||15 September 2008|
Xth EMOP, August 2008
Onchocerciasis control: biological research is still needed
Institut de Recherche pour le Développement (IRD), UR-024, 911, avenue Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
* Tel.: 33 (0)4 67 41 61 62 – E-mail: email@example.com
Achievements obtained by the onchocerciasis control programmes should not lead to a relaxation in the biological research on Onchocerca volvulus. Issues such as the Loa loa-related postivermectin serious adverse events, the uncertainties as to whether onchocerciasis can be eliminated by ivermectin treatments, and the possible emergence of ivermectin-resistant O. volvulus populations should be addressed proactively. Doxycycline, moxidectin and emodepside appear to be promising as alternative drugs against onchocerciasis but support to researches in immunology and genomics should also be increased to develop new control tools, including both vaccines and macrofilaricidal drugs.
Key words: onchocerciasis / Onchocerca volvulus / treatment / ivermectin / adverse reactions / elimination / resistance / genomics / vaccine
© PRINCEPS Editions, Paris, 2008, transferred to Société Française de Parasitologie
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.